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The risk factors for prostate cancer include a high-fat diet and obesity,
both of which are associated with an altered cell environment including
increased inflammation. It has been shown that chronic inflammation due
to a high-fat diet or bacterial infection has the potential to accelerate prostate cancer as well as its precursor, prostatic intraepithelial neoplasia
(PIN), development. However, the underlying mechanism of how chronic
inflammation promotes prostate cancer development, especially PIN,
remains unclear. In this study, we showed that more macrophages were
present in PIN areas as compared to the normal areas of human prostate.
When co-culturing PIN cells with macrophages in 3D, more PIN cells had
nuclear localized cyclin D1, indicating that macrophages enhanced PIN cell
proliferation. We identified ICAM-1 and CCL2 as chemoattractants
expressed by PIN cells to recruit macrophages. Furthermore, we discovered
that macrophage-secreted cytokines including C5a, CXCL1, and CCL2
were responsible for increased PIN cell proliferation. These three cytokines
activated ERK and JNK signaling in PIN cells through a ligand-receptor
interaction. However, only blockade of ERK abolished macrophage cytokines-induced cell proliferation of PIN. Overall, our results provide a mechanistic view on how macrophages activated through chronic inflammation
can expedite PIN progression during prostate cancer development. The
information from our work can facilitate a comprehensive understanding
of prostate cancer development, which is required for improvement of current strategies for prostate cancer therapy.

Abbreviations
AR, androgen receptor; CCL2, C-C chemokine ligand 2; COX-2, cyclooxygenase 2; CXCL1, C-X-C chemokine ligand 1; ECM, extracellular
matrix; EMT, epithelial–mesenchymal transition; ERK, extracellular signal-regulated kinase; H&E, hematoxylin and eosin; ICAM-1, intracellular
adhesion molecule-1; IL-6, interleukin 6; IjBa, nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor alpha; JNK, c-Jun Nterminal kinase; MDSC, myeloid-derived suppressor cell; NAb, neutralizing antibody; NF-jB, nuclear factor kappa-light-chain enhancer of
activated B cells; PARP, poly(ADP-ribose) polymerase; PGE2, prostaglandin E2; PIN, prostate intraepithelial neoplasia; PSGR, prostatespecific G protein-coupled receptor; PTEN, phosphatase and tensin homolog; STAT3, signal transducer and activator of transcription 3; STP,
staurosporine; TIMP-1, tissue inhibitor of metalloproteinases-1; TRAMP, transgenic adenocarcinoma mouse prostate.
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Introduction
Over the years, prostate cancer has maintained its
position as the second most commonly diagnosed form
of cancer in men only succeeded by skin cancer.
Approximately 175 000 men are diagnosed with prostate cancer annually with the median age of diagnosis
coming in at 65 years [1]. Fortunately, early detection
and isolation of the cancer to the prostate region leads
to a 5-year survival rate of nearly 100%. On the other
hand, prostate cancer that relocates to other regions of
the body, including bone and lymph node, significantly
decreases the chances of survival. Once the cancer
begins its migration to other areas of the body, the 5year survival rate drops to 30% and accounts for the
second leading cause of cancer death in men in the
United States making early detection critical [1].
Normal prostate glands consist of prostatic ducts
lined with epithelium and a stroma consisting of smooth
muscle cells. Benign tumor formation begins with
increased expression of fibroblasts and myofibroblasts
and decreased expression of smooth cell markers within
the stroma. The increase in fibroblasts and myofibroblasts causes heavy modification to the extracellular
matrix, while simultaneous interaction of tumorous
epithelial cells creates a safe microenvironment for
tumor maturation [2–4]. This abnormal neoplastic, precancerous growth of the epithelial cells lining the internal and external surfaces of the prostate gland is known
as prostatic intraepithelial neoplasia or PIN and is considered the precursor to prostate cancer [5,6].
Although PIN is not considered cancer but rather a
precursor lesion, it does require essential features that
are conducive for tumor growth, proliferation, and
maturation. PIN formation is also considered a necessary step in the development of prostate cancer and
tumor construction. PIN, based on a diagnostic measure, can be divided into two different categories, lowgrade PIN and high-grade PIN [5]. As the epithelial
cells lining the acini and ducts of the prostate become
increasingly abnormal, the transition from low-grade
PIN to high-grade PIN, where cells have taken on new
characteristics, becomes more visible. Furthermore,
high-grade PIN can provide the proper environment
for tumor cells to grow and proliferate [5,7,8].
Cell microenvironment is critical to tumor initiation
and development. So far, little is known about the role
of inflammation during PIN development. What is
known, however, is that immune cells including macrophages secrete cytokines and chemokines which influence the cells surrounding the prostate epithelial cells.
Within the prostate cancer area, hematopoietic cells
are recruited to the area by various signaling factors
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and are polarized into pro-inflammatory or anti-inflammatory macrophages [9,10]. In return, an influx of
pro-inflammatory cytokines and chemokines is released
from the newly differentiated macrophages creating
areas of inflammation [11]. Meanwhile, fibroblasts and
myofibroblasts within the PIN area cause heavy modification to the extracellular matrix. Consequently, the
ECM modification coupled with dense areas of inflammation creates an impregnable barrier that prevents
cytotoxic T cells from exerting their effects on the
tumorous cells. Furthermore, the tumor microenvironment is considered hypoxic [12–14]. Lack of oxygen
starves the tumor of essential nutrients leading to the
recruitment of new blood vessels being formed by
growth factors that are secreted by the same pro-inflammatory macrophages in the PIN area.
Altogether, the components of the PIN area work in
harmony to provide an environment conducive for
tumor growth. The abundance of cytokines, chemokines, and growth factors within the PIN area are thought
to provide adequate stimulation for tumor progression
and enhance cellular proliferation as it relates to cancer.
Our current study demonstrates the importance of
macrophages within the PIN area and the role they play
in tumor development. We show that macrophages were
able to increase the numbers of nuclear cyclin D1-positive PIN cells, suggesting macrophages play a role in
expediting cell proliferation. Furthermore, later tests
showed that PIN cells secreted chemoattractants, notably ICAM-1 and CCL2 cytokines, to attract macrophages to the area. We also demonstrated that
macrophage-secreted cytokines including C5a, CXCL1,
and CCL2 function as a signaling stimulus, which act to
enhance or decrease various pathways including JNK
and ERK, which have been noted for their function in
cellular proliferation. However, only blockade of ERK
decreased PIN cell proliferation indicating the role of
ERK signaling in regulating macrophage-stimulated cell
proliferation of PIN. Altogether, our work provided a
mechanistic view on how macrophages are recruited by
PIN cells to expedite PIN cell proliferation during the
prostate tumor progression.

Results
Infiltration of macrophages in human prostate
intraepithelial neoplasia and their effect on PIN
cell proliferation
Accumulating evidence has indicated a pivotal role for
the cell microenvironment in prostate disorders including prostate cancer. The cell microenvironment is influenced by surrounding immune cells that secrete
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cytokines, chemokines, and growth factors that regulate prostate epithelial cells during cancer initiation,
development, and dissemination. To determine
whether macrophages are the source of cytokines or
chemokines during the development of prostate
intraepithelial neoplasia, or PIN, we utilized immunohistochemistry in an attempt to evaluate macrophage
density in human tissues of normal prostate and PIN
(Fig. 1A). Increased macrophage infiltration was
observed in the PIN area as compared to the normal
prostate tissue samples, suggesting a potential role for
macrophage contribution to prostate cancer development. To test the effect of macrophages on PIN cell
proliferation, we plated murine Pr111 PIN cells [15] on
matrigel in 3D cocultured with or without primary
macrophages for 72 h. At the endpoint, Pr111 cells
were fixed in 3D and then stained for cyclin D1, a
A

surrogate marker for cell proliferation [16–18], for
immunocytochemistry analysis (Fig. 1B and Fig. S1).
As shown in Fig. 1B, cocultured with primary macrophages, more Pr111 PIN cells were positive for nuclear
cyclin D1 as compared to when Pr111 cells were cultured alone. The increased fold of nuclear cyclin D1 of
Pr111 cells cultured with primary macrophages was
almost exactly same as that of Ki-67 as the cell proliferation indicator (Fig. S1B), indicating that nuclear
cyclin D1 is a compatible cell proliferation indicator as
to Ki-67. When Raw264.7 macrophages were used to
coculture with Pr111 cells, we detected the same effect
of Raw264.7 macrophages on increased numbers of
nuclear cyclin D1-positive Pr111 cells (Fig. 1C and
Fig. S2). Furthermore, the cocultured Raw264.7
macrophages were also nuclear cyclin D1 positive, suggesting that these macrophages were proliferating
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Fig. 1. Infiltrating macrophages in the PIN promote cell proliferation. (A) Normal prostate and prostate cancer sample containing the area of
PIN of human tissues were immunostained with the antibody of CD68, a marker for macrophages (Top Panel). The tissue samples were
also stained with hematoxylin and eosin (H&E) to visualize the morphology (Bottom Panel). Scale bar: 50 µm. The PIN figure shown is
representative of five human tissue samples. (B) Murine PIN Pr111 cells were cultured with or without primary peritoneal macrophages on
matrigel in 3D. At the endpoint, the cells were fixed, permeabilized and immunostained with cyclin D1 (green), a surrogate marker for cell
proliferation. Cell nuclei were stained by DAPI (blue). Cell proliferation index of Pr111 cells under these two conditions was quantified. Scale
bar: 20 µm, *P < 0.05 as compared to control (without primary macrophages; student t test), n = 3 (C) Murine PIN Pr111 cells were
cultured with or without Raw264.7 macrophages on matrigel in 3D. At the endpoint, the cells were fixed, permeabilized, and
immunostained with cyclin D1 (green), a surrogate marker for cell proliferation. Cell nuclei were stained by DAPI (blue). Cell proliferation
index of Pr111 cells under these two conditions was quantified. Scale bar: 20 µm. The data was analyzed by Student’s t test. *P < 0.05 as
compared to control (without Raw264.7 macrophages), n = 5.
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under the coculture conditions (Fig. S3). Altogether,
our results suggest that infiltrating macrophages in the
PIN area expedite PIN cell proliferation.
PIN cells expressed chemoattractants that
mediate macrophage infiltration
Because macrophages were infiltrating into the PIN areas
of human prostate (Fig. 1A), we investigated whether or
not PIN cells are able to attract macrophages. We first
in vivo labeled murine Pr111 cells and Raw264.7 cells with
Vybrant DiI (Red) and Vybrant DiO (green), respectively,
and then seeded each type of cells in 3D in the separate
compartments of a co-cultivation system (Fig. 2A, left
panel). Seventy-two hours after coculture, we detected
macrophage clusters physically attached to PIN cells
(Fig. 2A, right panel). Our observation shows that macrophages were attracted to PIN cells but through an
unknown mechanism. We determined one possibility may
be through chemoattractants expressed by PIN cells
resulting in macrophage migration. To identify the potential chemoattractants that mediate macrophage attraction
toward Pr111 PIN cells, we subjected the collected conditioned media of our 3D coculture system and the control
media to cytokine profiler arrays. Among 40 tested
cytokines, only five cytokines including C5a, ICAM-1,
CXCL1, CCL2, and TMP-1 were present in the coculture
media (Fig. 2B). Among these five identified cytokines,
C5a, ICAM-1, and CCL2 have been reported to function
as chemoattractants for immune cells [19–25]. To determine whether these chemokines were expressed by PIN
cells resulting in macrophage attraction, we treated our
3D coculture system of Pr111 cells and macrophages with
the neutralizing antibodies specifically against C5a,
ICAM-1, or CCL2 followed by attraction assay (Fig. 2C,
D). Blockade of C5a using the C5a neutralizing antibody
had no effect on macrophage attraction (Fig. 2C).
Instead, treatment of ICAM-1 neutralizing antibody,
CCL2 neutralizing antibody or both significantly
decreased macrophage infiltration to PIN cells (Fig. 2D).
Furthermore, results from immunohistochemistry analysis indicated that expression of ICAM-1 and CCR2 was
increased in PIN cells of the human prostate in comparison with the normal prostate (Fig. 2E,F).
Macrophage cytokines promoted PIN cell
proliferation without affecting apoptosis
In addition to macrophage attraction, macrophages also
potentiated murine PIN Pr111 cell proliferation as shown
in Fig. 1B. To evaluate whether the identified cytokines
secreted from macrophages can also regulate cell proliferation of PIN, we treated the Pr111 cells in 3D setting with
1874
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recombinant C5a. At the endpoint, we utilized immunocytochemistry to assess the nuclear cyclin D1 localization
as a readout for cell proliferation to avoid any artificial
effects from disrupting the 3D setting. Exogenous addition of recombinant C5a increased Pr111 cell proliferation
(Fig. 3A). The same effects were also detected in the cells
treated with either recombinant CCL2 or CXCL1
(Fig. 3B,C). Interestingly, when treating cells with either
each of the recombinant C5a, CCL2, and CXCL1, in a
combination of either one or all three cytokines, all of
them were able to promote PIN cell proliferation
(Fig. 3D). Notably, there were no additive promoting
effects of cell proliferation in the presence of all three
cytokines in our 3D coculture setting, suggesting that
these cytokines use similar pathways to regulate cell proliferation of PIN. An increased expression of CD88 and
CCR2, the receptor for C5a and CCL2, respectively, was
present in the human tissue samples of PIN (Figs 2F and
3E). Furthermore, the cultured Pr111 PIN cells expressed
CXCR2, the receptor for CXCL1, and CCR2, the receptor for CCL2 (Fig. S4). Meanwhile, elevated expression
of C5a and CCL2 mRNA levels were in Raw264.7 macrophages cultured in PIN media but not in the control
media (Fig. S5). It has been reported that CXCL1 is associated with anti-apoptosis in the prostate epithelial cells
[26]. To test the possibility that these identified macrophage cytokines including C5a, CXCL1, and CCL2 may
affect apoptosis of PIN cells, we examined the presence of
cleaved poly-(ADP-ribose) polymerase (PARP), which is
a product of activated caspases during apoptosis in our
system [27–29]. As shown in Fig. S6, Pr111 PIN cells treated with C5a, CXCL1, or CCL2 under the 3D culture setting had no effect on apoptosis as compared to control
cells, whereas NIH3T3 cells treated with staurosporine
(STP), which is well documented to induce apoptosis
[30,31], underwent apoptosis as indicated by the presence
of the cleaved fragment of PARP. Altogether, these
results suggested that C5a, CXCL1, and CCL2 secreted
by macrophages were capable of regulating PIN cell proliferation without affecting apoptosis through a ligand-receptor interaction.
Blockade of macrophage cytokines attenuated
PIN cell proliferation
Next, we evaluated the effects of the macrophage-secreted cytokines that were identified from our 3D
cocultured experiments on PIN cell proliferation by
blocking each individual cytokine through their specific neutralizing antibody. Murine Pr111 PIN cells were
cultured in matrigel in 3D and stimulated with the
macrophage conditioned media in the presence of
either isotype matched control antibody or C5a
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Fig. 2. ICAM-1 and CCR2 expressed by PIN mediate cell attraction between macrophages and PIN cells. (A) A diagram for demonstrating
cell co-cultivation of Pr111 cells and Raw264.7 macrophages that were in vivo labeled with Vybrant DiI (Red) and Vybrant DiO (green),
respectively. Cells were plated on matrigel in 3D in µ-Slides (Ibidi) and overlaid with PrEBM complete media. Fluorescent and bright-field
pictures of Pr111 and Raw264.7 cells were taken at 0 and 72 h of coculture. Scale bar: 25 µm. n = 3. (B) Raw264.7-coculture media and
control media were subjected to a mouse cytokine array for identifying the cytokines present in Raw 264.7-coculture media. A1/2, A23/24,
and F1/2 contain positive controls, and F23/F24 contains negative controls. (C, D) Similar to A, Pr111 cells grown on matrigel in 3D were
cocultured with Raw264.7 cells in the presence of isotype control antibody or the neutralizing antibody against the cytokines identified from
Raw264.7-coculture including C5a (C), ICAM-1 and CCL2 (D). The data shown in C and D are representative of three independent
experiments. Cell attraction between Pr111 and Raw264.7 cells under these treatments were evaluated 72 h after co-culture and quantified.
Scale bar: 25 µm. The data were analyzed by one-way ANOVA with Tukey-Kramer post hoc test. *P < 0.05 as compared to isotype control
NAb, n = 3. (E, F) Normal prostate and prostate cancer sample containing PIN of human tissues were immunostained for expression of
ICAM-1 (E) and CCR2 (F). The figure shown is representative of three human tissue samples. Scale bar: 50 µm.
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Fig. 3. Macrophage cytokines C5a, CCL2 and CXCL1 upregulate cell proliferation of PIN cells. (A–C) Murine PIN Pr111 cells grown on
matrigel in 3D were treated with the cytokines identified from Raw264.7-coculture media including C5a (A), CCL2 (B), and CXCL1 (C) at the
indicated concentrations. Seventy-two hours post-treatment, the cells were fixed, permeabilized, and immunostained with cyclin D1 (green).
The cell nuclei were visualized by DAPI staining (blue). Cell proliferation index of Pr111 cells under these treatments was quantified. Scale
bar: 25 µm, *P < 0.05 as compared to control [Student’s t test for C5a (A); one-way ANOVA and multiple comparisons for CXCL1 (B) and
CCL2 (C)], n = 5. (D) Similar to A, Pr111 cells were treated with either the identified cytokines alone or any combination of the identified
cytokines as indicated. Cell proliferation index under these conditions was quantified. The data were analyzed by one-way ANOVA with
Tukey-Kramer post hoc test. *P < 0.05 as compared to the control/vehicle, n = 3. (E) Normal prostate and prostate cancer sample
containing PIN of human tissues were immunostained for CD88 expression. The figure shown is representative of three human tissue
samples. Scale bar: 50 µm.

neutralizing antibody/C5a NAb (Fig. 4A). Treatment
of C5a NAb reduced the number of Pr111 cells that
had nuclear cyclin D1, a surrogate marker for cell proliferation, suggesting that blockade of C5a diminished
macrophage-induced PIN cell proliferation. Similarly,
neutralization of either CXCL1 or CCL2 through the

CXCL1 NAb and CCL2 NAb also attenuated macrophage-caused cell proliferation of Pr111 PIN cells
(Fig. 4B,C). However, when treated with all three neutralizing antibodies including C5a, CXCL1, and
CCL2, there was no additive inhibitory effect on PIN
cell proliferation in comparison with each individual

Fig. 4. Blockade of C5a, CCL2 or CXCL1 attenuate PIN cell proliferation induced by macrophage conditioned media. (A–D) Pr111 cells
grown on matrigel in 3D were treated with Raw264.7 macrophage conditioned media in the presence of isotype control antibody or the
neutralizing antibody of C5a (A), CXCL1 (B), CCL2 (C), or all three (D) for 72 h. The cells were fixed, permeabilized and immunostained with
cyclin D1 (green). The cell nuclei were stained and visualized with DAPI (blue). Cell proliferation index of Pr111 cells under these conditions
was quantified. Scale bar: 25 µm. The data were analyzed by Student’s t test. *P < 0.05 as compared to isotype control antibody, n = 3.
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NAb (Fig. 4D). Altogether, these results further bolster our previous conclusion from the experiments
which we stimulated PIN cells with recombinant
cytokines, C5a, CXCL1, and CCL2 (Fig. 3).

PIN cell proliferation, we isolated Pr111 cells that were
stimulated by C5a, CXCL1 or CCL2 from our 3D culture system and then subjected them to immunoblotting analysis for the pathways described above.
Macrophage cytokine C5a elevated phosphorylated
ERK1/2, but had no effect on phosphorylated Akt,
suggesting that C5a activates the ERK pathway
(Fig. 5A and Fig. S7A). Activation of NF-jB transcription factor requires the phosphorylation of its
inhibitory suppressor protein IjBa followed by the
IjBa degradation through proteasome machinery
[40,41]. As judged by the levels of phosphorylated
IjBa, which is a readout for activation of NF-jB,

Macrophage cytokines activated ERK and JNK in
PIN cells
Several signaling pathways are well-known regulators
of cell proliferation including ERK, Akt, NF-jB,
JNK, and p38 MAP kinase [16,32–39]. To test which
signaling pathways are activated by the macrophage
cytokines, C5a, CXCL1, and CCL2, which promote
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Fig. 5. Activation of ERK and JNK in PIN cells stimulated by macrophage cytokines C5a, CCL2, or CXCL1. (A–C) Pr111 cells grown on
matrigel in 3D were treated with either control/ddH2O or recombinant C5a for 72 h. Cell lysates were collected and subjected to
immunoblotting for examining the protein of interests including p-ERK, ERK, p-AKt and Akt (A); p-IjBa (B); p-JNK, JNK, p-p38 MAPK, and p38 MAPK (C). (D–F) Similar to A–C, Pr111 cells cultured on matrigel in 3D were treated with control, recombinant CXCL1 or CCL2. Cell
lysates were collected from 3D culture and subjected to immunoblotting for examining the levels of p-ERK, ERK, p-AKt, and Akt (D); p-IjBa
(E); p-JNK, JNK, p-p38 MAPK, and p-38 MAPK (F). The relative intensity fold change was calculated by the ratio of phosphorylated protein
levels over the corresponding total protein levels and set as 1 for control in each case. Each image shown in A–F was representative of 3–5
independent experiments. (G) Normal prostate and prostate cancer sample containing PIN of human tissues (n = 3 per group) were
immunostained for phosphorylated-ERK expression. Scale bar: 50 µm.
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treatment of C5a had no effect on NF-jB pathway in
Pr111 cells (Fig. 5B). Similarly, C5a did not activate
p38 MAP kinase and only slightly increased phosphorylated JNK (Fig. 5C and Fig. S7C). Meanwhile, both
macrophage cytokines CXCL1 and CCL2 activated
ERK but slightly decreased phosphorylated Akt
(Fig. 5D and Fig. S7B). Neither cytokines, CXCL1 or
CCL2, activated NF-jB nor p38 MAP kinase pathways (Fig. 5E,F). Furthermore, these two cytokines
also activated JNK, especially in CCL2-treated Pr111
cells. Among these examined pathways, ERK activation was the strongest one in Pr111 PIN cells in our
3D culture system. We next utilized immunohistochemistry to analyze phospho-ERK levels in the
human tissue samples to vindicate our in vitro results.
As shown in Fig. 5G, elevated levels of phosphorylated ERK were detected in the PIN areas of prostate
cancer patients compared to normal prostate. Meanwhile, little difference was observed among the activated Akt expression between the PIN areas and the
normal prostate tissue (Fig. S8). These results further
support our in vitro data for ERK activation in PIN
cells.
Effect of blockade of ERK or JNK on PIN cell
proliferation
Our immunoblotting results suggested differential
intensity of ERK and/or JNK activation in Pr111 PIN
cells in response to macrophage cytokines, C5a,
CXCL1, and CCL2 stimulation in the 3D setting. To
test whether these two signaling pathways are responsible for PIN cell proliferation, we treated Pr111 PIN
cells with either ERK inhibitor U0126 or JNK inhibitor SP600125 in our 3D culture system in the presence
of C5a, CXCL1 or CCL2 (Fig. 6A,B). When treated
with recombinant C5a, CXCL1, or CCL2, macrophage
cytokines, an increase of Pr111 cell proliferation was
detected and confirmed by the nuclear cyclin D1 localization (Fig. 6A). In addition, the increased cell proliferation was abolished by treating cells with U0126, the
ERK inhibitor. Interestingly, blockade of JNK activation through SP600125 only impaired C5a-, but not
CXCL1- nor CCL2-induced Pr111 cell proliferation
(Fig. 6B). Altogether, these results suggested that
macrophage-secreted cytokines including C5a, CXCL1,
and CCL2 regulate PIN cell proliferation mainly
through activation of ERK.

Discussion
The cell environment plays a critical role in the initiation and development of cancer. With different types
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of cells such as immune cells, endothelial cells, and
fibroblasts being nearby, the dynamic interactions
between these cells and epithelial cells determine tumor
onset and progression. Although there is a discrepancy
of clinical reports in regards to the relationship
between inflammation and prostate cancer [42–45], several lines of evidence from laboratory bench work and
animal studies have indicated an inflammatory environment during prostate cancer development [46–50].
Xenografting of the immortalized nontumorigenic
RWPE-1 cells with THP-1 monocytes in nude mice
were able to develop tumors due to an epithelial–mesenchymal transition (EMT) of nontumorigenic prostate epithelial cells by the androgen receptor (AR) of
THP-1 monocytes [46]. In addition, knockout of AR
in macrophages reduced PIN formation in PTEN+/
transgenic mice. Intra-urethral administration of bacteria Escherichia coli in the C3H/HeJ mouse model
induced severe chronic inflammation and subsequent
prostate epithelial dysplasia which mimic high grade
PIN [47]. Furthermore, the dysplastic cells possessed
elevated cell proliferation through a decrease of CDK
inhibitor p27Kip1, high levels of oxidative DNA damage, and loss of AR and PTEN. Our current work
demonstrated that Raw264.7 macrophages promoted
cell proliferation of murine Pr111 PIN cells that were
established from low-grade PIN lesions in C3(1)/Tag
transgenic model of prostate cancer in a 3D coculture
(Fig. 1), thus providing the first direct evidence on the
role of inflammation in PIN development and progression. Although there is emerging evidence supporting
the notion that chronic inflammation leads to prostate
cancer development, whether prostate epithelial cells
play a role in modulating this process remains completely unknown. With the live labeling dye technique
to distinguish macrophages and PIN cells, we showed
that prostate epithelial tumor cells attracted macrophages through ICAM-1 and CCR2 (Fig. 2). This
chemoattraction allows more macrophages to be
recruited to the areas where PIN cells are and creates
a proximity for the macrophages-secreted cytokines
including C5a, CXCL1, and CCL2 to activate the cell
signaling of PIN cells (Fig. 5).
For the first time, we have identified the cytokines
C5a, CXCL1, and CCL2 secreted by macrophage from
a 3D coculture system with PIN Pr111 cells. We also
showed that each of these cytokines activated the same
signaling pathways in PIN cells to enhance PIN cell
proliferation during prostate tumor development and
progression. Notably, the specific receptors CD88,
CXCR2, and CCR2 for macrophage cytokine C5a,
CXCL1, and CCL2 are present in PIN cells (Figs 2F
and 3E, and Fig. S2), suggesting a ligand-receptor
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Fig. 6. Macrophage-secreted cytokines promote PIN cell proliferation through activation of ERK but not JNK. (A, B) U0126, a specific ERK
inhibitor (A), or SP600125, a specific JNK inhibitor (B) was added to 3D cultures of murine PIN Pr111 cells that were treated with either
control/ddH2O, C5a, CXCL1, or CCL2 for 72 h. Vehicle (DMSO) was used as control. Cell proliferation index under these conditions was
quantified. The data were analyzed by one-way ANOVA with Tukey–Kramer post hoc test. *P < 0.05 as compared to the control + vehicle,
**P < 0.05 as compared to vehicle + individual cytokine, n = 3. (C) A scheme to summarize how macrophages are attracted to PIN cells to
promote cell proliferation of PIN.

mechanism used by PIN cells to activate the downstream portion of the cell signaling in response to these
macrophage cytokines. Among the three identified
macrophage cytokines, C5a anaphylatoxin is a cytokine-like polypeptide produced during complement
system activation and released at the inflammatory
site. Knowledge surrounding cytokine involvement in
prostate cancer initiation and precancerous lesion
growth has never been fully explained. However, our
analysis demonstrates that C5a plays a role in expediting PIN cell proliferation during prostate tumor development. In addition to regulating cancer proliferation,
metastasis, angiogenesis, and apoptosis, the most wellknown function of C5a during cancer development is
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to attune the microenvironment such as activation of
myeloid-derived suppressor cells (MDSC) for cancer
cells to prosper [51–54].
Previously, CXCL1 and CCL2 had not been
reported to function as macrophage cytokines in the
prostate cancer field. However, both cytokines were
shown to be upregulated in the prostate cancer cells
and controlled cancer cell proliferation and dissemination. Elevated expression of CXCL1 was detected
in high-grade prostate cancer [55]. It has also been
shown that prostate cancer patients who are obese
expressed high levels of CXCL1 in their prostate tissues [56]. Moreover, blockade of CXCL1 signaling
through shRNA or neutralizing antibody impeded
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the recruitment of adipose stromal cells to the prostate cancer and vascularization in the cancer areas
that promote cancer growth. Intriguingly, a high-fat
diet not only potentiates prostate cancer growth but
also hinders the survival rate of the transgenic adenocarcinoma
mouse
prostate
(TRAMP)
and
TRAMP-C2 allograft mice [57]. CCL2 is upregulated
in prostate cancer cells and smooth muscle cells of
the prostate gland [58–60]. Furthermore, a very large
body of evidence has demonstrated its role in promoting prostate cancer cell proliferation, migration,
bone metastasis, and drug resistance [59,61–66]. This
also includes evaluations for the use of CCL2 neutralizing antibody as adjuvant therapy to treat prostate cancer [61,67].
Our current work showed the activation of ERK
and JNK in the PIN cells when stimulated by the
macrophage-secreted cytokines C5a, CXCL1, or CCL2
(Fig. 5). However, only blockade of ERK completely
impeded macrophage cytokines-induced cell proliferation of PIN (Fig. 6), indicating the function of ERK
signaling in promoting PIN cell growth adding a new
pathway for modulating PIN progression. In addition
to our findings, there are several signaling pathways
reported to regulate PIN formation. Overexpression of
prostate-specific G-protein-coupled receptor (PSGR)
via a probasin promoter in prostate cells induced
chronic inflammation as well as subsequent PIN formation in mice [68]. In addition, more CD68+ macrophages were detected in the PSGR-induced PIN areas
and activation of NF-jB in PIN cells in response to
PSGR expression. In addition to elevated expression
of cyclooxygenase (COX)-2 and prostaglandin E2
(PGE2) in PIN, treatment of a human PIN cultured
cell line with PGE2 caused soluble IL-6 receptor
release, gp130 dimerization, STAT3 phosphorylation,
and eventually accelerated cell proliferation [69]. It has
been shown that using the morphoproteomic analysis
technique to examine the human prostate cancer and
high grade PIN in the tissue microarray, activation of
mTOR, a protein kinase that regulates protein synthesis and cell growth, was elevated in both cancer and
PIN samples, implicating the role of the Akt/mTOR
signaling pathway in PIN growth [70]. Dysregulation
of Notch signaling which controls cell proliferation
and differentiation during embryogenesis and adult tissues has been tightly associated with cancer development. Interestingly, it has been reported that higher
levels of all members of Notch signaling including
Notch1-4, Jagged1-2, Delta, HES1, and HES5 were in
high grade PIN of human tissue samples [71]. In addition, Notch1, Notch4, HES1, and Jagged1 were the
four most highly expressed proteins. Future studies for
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examining the role of these four Notch signaling molecules in PIN progression are required.

Materials and methods
Cell lines, antibodies, and reagents
Raw 264.7 macrophage cells (ATCC, Manassas, VA, USA)
were cultured in RPMI 1640 containing 10% FBS and
100 UmL 1 penicillin/streptomycin. Pr111 cells were cultured on collagen I-coated dishes and maintained as
described previously [15]. In brief, Pr111 cells were grown in
PrEBMTM prostate epithelial cell growth basal media supplemented with MEGM singlequots, 2% FBS, 1 mM sodium
Pyruvate,
10 nM
dihydro-testosterone,
and
100 UmL 1 penicillin/streptomycin. Cells were maintained
in a 37 °C incubator supplemented with 5% CO2. The passage number of Pr111 cells was less than 10 passages in all
experiments. To obtain Raw 264.7-conditioned media,
2.5 9 105 cells per 6-well dish were cultured in Pr111 complete media for 3 days, and supernatant was collected. Conditioned media were freshly prepared for each experiment.
All neutralizing antibodies that target murine C5a, CXCL1,
and CCL2 as well as the isotype control antibodies were purchased from R&D systems (Minneapolis, MN, USA). Murine ICAM-1 neutralizing antibody and its isotype control
antibody were from BioLegend (San Diego, CA, USA). The
anti-CD68 antibody was from DAKO (Santa Clara, CA,
USA); anti-cyclin D1 antibody was from Thermo Fisher Scientific (Waltham, MA, USA); anti-ICAM-1 antibody was
obtained from Abcam (Cambridge, MA, USA); anti-CD88
antibody was from Bio-Rad (Hercules, CA, USA). The antiCCL2 antibody was from Novus Biologicals (Centennial,
CO, USA); anti-Akt, anti-phospho-Akt (ser473), anti-ERK,
anti-JNK, anti-phospho-JNK, anti-p38 MAPK, anti-phospho-p38 MAPK, and anti-phospho-IjBa antibodies were
purchased from Cell Signaling Technology (Danvers, MA,
USA). The anti-phospho-ERK1/2 antibody was from Santa
Cruz Biotechnology (Dallas, TX, USA). Mouse recombinant
CXCL1 and CCL2 were purchased from PeproTech (Rocky
Hill, NJ, USA). Mouse recombinant C5a was from ProSpec
(Rehovot, Israel). Matrigel was from Corning (Corning,
NY, USA). U0126 and SP600125 were obtained from Cell
Signaling Technology and Tocris Bioscience (Bristol, UK),
respectively. Other reagents used are described in the specific
experiment sections.

Chemoattraction assays
Pr111 cells and Raw 264.7 macrophages were in vivo
labeled with Vybrant DiI (Red) and Vybrant DiO (green)
(Invitrogen, Carlsbad, CA, USA) under the manufacture’s
instruction. Cells were separately seeded on top of 50%
matrigel of ibid 2 9 9 well µ chamber slide. The chamber
slide does not allow an initial physical contact between two
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cell types other than sharing the culture media. 2 9 103 Dil
labeled Pr111 cells were seeded in the center of the chamber
slide and surrounded by 2.5 9 103 DiO-labeled Raw 264.7
cells in each separate space. The indicated specific neutralizing antibody or isotype control antibody with the final concentrations (C5a NAb: 2 ngmL 1; ICAM-1 NAb:
0.625 µgmL 1; CCL2 NAb: 18 ngmL 1) was immediately
added to the shared culture media after cell seeding. The
NAbs and their matching isotype antibody were replenished every 24 h. After 72 h, macrophages migrated to the
Pr111 cell clusters in the center of the chamber slide were
visualized using a Zeiss Axiovert 200M (Carl Zeiss Microscopy, LLC, White Plains, NY, USA) inverted fluorescent
microscope. The entire field of the center compartment of
the chamber slide where Pr111 cell clusters were located
was photographed and analyzed for the interaction of
Pr111 and Raw 264.7 cells.

Isolation of primary macrophages
Primary murine macrophages were isolated as previously
described [72,73]. In brief, mice were intraperitoneally
injected with 2 mL of 3–5% aged thioglycollate solution.
On day 5 after injection, peritoneal macrophages were collected through a single injection of 10 mL RPMI-1640 containing 10% FBS into the peritoneal cavity and subsequent
withdrawal. The peritoneal exudate was centrifuged and
washed with RPMI-1640 media containing 10% FBS
before plating onto tissue culture dishes. After 1 h at 37 °C
incubator supplemented with 5% CO2, cells were vigorously washed with PBS three times to remove nonadherent
macrophages and immediately used to coculture with Pr111
cells in Pr111 complete media in 3D.

3D culture of Pr111 cells and treatment
Pr111 single cells were plated on top of 50% matrigel and
stimulated with the indicated recombinant proteins with the
indicated concentrations or vehicle control. For Raw 264.7
macrophage conditioned media induced cell proliferation,
the indicated specific neutralizing antibodies or isotype control antibodies with a final concentration of 1 µgmL 1
were immediately added to the culture after cell seeding.
The NAbs and their matching isotype antibody were
replenished every 24 h. For treatment, 2.5 µM U0126, 1 M
SP600125 or vehicle DMSO was added to the cells simultaneously with or without the indicated recombinant proteins
after cells were seeded on matrigel.

Cell proliferation assay
The method has been described in our earlier publication
[16]. In brief, Pr111 cells grown in 3D matrigel culture with
the indicated stimulation/treatment for 72 h were rinsed
twice with PBS [140 mM NaCl, 2.7 mM KCl, 8 mM
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Na2HPO4, and 1.5 mM KH2PO4 (pH 7.2)], fixed with 4%
paraformaldehyde-PBS for 20 min, permeabilized with 1%
Triton X-100 in PBS for 10 min, 0.5% Triton X-100 in
PBS for 20 min, 0.1% SDS in PBS for 1 min, and blocked
in 10% goat serum 1 h at room temperature. Samples were
incubated with anti-cyclin D1 antibody (1 : 250) overnight
at 4 °C. Samples were washed three times with PBS containing 0.05% Tween-20. Secondary antibodies Alexa Fluor
488 goat-anti-rabbit (1 : 500) from Thermo Fisher Scientific
were added for 30 min at room temperature. After another
three washes of PBST, DAPI was used to label cell nuclei.
Images were visualized in ibidi mounting media. Serial sections of images (Z-stack) were captured by a Zeiss Axiovert
200M inverted fluorescent microscope with a 209 objective
lens. Each 3D image was reconstructed from Z-stack
images. Numbers of nuclear cyclin D1 were counted in randomly five 3D images per condition. Cell proliferation
index was calculated using the ratio: numbers of nuclear
cyclin D1/numbers of all cells (DAPI).

Cellular lysates and immunoblotting
Cells were washed twice with PBS, lysed in buffer A
[50 mM Tris/HCl (pH 7.4), 1% Triton X-100, 150 mM
NaCl, and 5 mM EDTA (pH 7.4)] or RIPA buffer [25 mM
Tris/HCl (pH 7.5), 1% Triton X-100, 140 mM NaCl, 1 mM
EDTA, 0.5% SDS] supplemented with protease inhibitor
cocktail (Thermo Fisher Scientific), incubated on ice for
30 min and centrifuged at 4 °C, 18 407 g for 10 min. The
supernatants were subjected to SDS/PAGE, and resolved
proteins were transferred onto nitrocellulose membranes.
The membranes were blocked in 5% BSA in TBST [50 mM
Tris/HCl (pH 7.6), 150 mM NaCl, 0.05% Tween-20] and
incubated with the antibodies of interest in 5% BSA in
TBST overnight at 4 °C. The appropriate horseradish peroxidase-conjugated 2° antibodies were applied for 30 min
at room temperature. Samples were visualized with ECL
and X-ray film.

Immunohistochemistry
Human prostate tissue slides were purchased from BioChain (Newark, CA, USA), Origene (Rockville, MD,
USA), and Cooperative Human Tissue Network (CHTN).
Slides were deparaffinized in three changes of xylene and
gradually rehydrated through enthanol to distilled water.
The rehydrated slides subjected to 10 mM sodium citrate
buffer (pH 6.0) and then rinsed with distilled water. Slides
were treated with 3% hydrogen peroxide for 5 min to
reduce endogenous peroxidase activity and washed with
PBS containing 0.5% Tween-20. Slides were blocked with
protein block serum free solution (DAKO) for 10 min at
RT. Primary antibody [CD68 1 : 500 (DAKO); ICAM-1
1:50 (Abcam, Cambridge, UK); CCR2 1 : 1000 (Novus
Biologicals, Littleton, CO, USA); CD88 1 : 500 (Bio-Rad);
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phospho-ERK 1 : 150 (Santa Cruz Biotechnology) was
incubated in antibody diluent background reducing solution (DAKO) and visualized using the ImmPRESS Polymer
Detection Kit (Vector Laboratories, Burlingame, CA,
USA)] according to the manufacturer’s instructions. Images
were captured using Aperio VERSA tissue scanner with IMAGESCOPE software (Aperio, Sausalito, CA, USA).

Cytokine array
The cytokines secreted by Raw 264.7 macrophages cultured
in the Pr111 complete media for 3 days, which is the coculture condition, as previously described in the Cell Lines,
Antibodies, and Reagents, were examined using the Proteome Profiler Mouse Cytokine Array Kit (R&D Systems)
according to the manufacturer’s instructions.

Statistical analysis
Data are presented as means  SE. P-values were acquired
with the Student’s t test for comparing two sets of data
using PRISM (GraphPad Software, San Diego, CA, USA).
For more than two sets of data, one-way ANOVA analysis
along with multiple comparisons Tukey-Kramer post hoc
test was carried out using PRISM (GradPad Software).
P < 0.05 is considered statistically significant.

Acknowledgements
Mikalah Thomas was partially supported by the NIH/
NIMHD/RCMI program Grant No. 2U54MD00759032 and by NIH RISE program Grant No.
5R25G06414-16. This work was supported in full by
the NIH/NIMHD/RCMI program Grant No.
2U54MD007590-32 and partially supported by the
NIH RISE program Grant No. 5R25G06414-16. The
content is solely the responsibility of the authors and
does not necessarily represent the official views of the
National Cancer Institute or the National Institutes of
Health. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest
The authors declare no conflict of interest.

Author contributions
G-YL involved in the conception and design. MUT,
TD, JKM, and G-YL involved in the acquisition of
data. G-YL, MUT, JKM, and TD involved in the
analysis and interpretation of data. JKM, G-YL, and
SAA involved in the writing, review and/or revision of

Macrophages accelerate cell growth of prostate cancer precursors

the manuscript. G-YL supervised the study. CLJ, SAA
performed other (developed and provided a cell line,
tissue samples).

References
1 Oncology ASoC (2019) Prostate Cancer: Statistics.
2 Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G
& De Maria R (2019) Cancer-associated fibroblasts as
abettors of tumor progression at the crossroads of EMT
and therapy resistance. Mol Cancer 18, 70.
3 Otranto M, Sarrazy V, Bonte F, Hinz B, Gabbiani G &
Desmouliere A (2012) The role of the myofibroblast in
tumor stroma remodeling. Cell Adh Migr 6, 203–219.
4 Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang
TD & Rowley DR (2002) Reactive stroma in human
prostate cancer: induction of myofibroblast phenotype
and extracellular matrix remodeling. Clin Cancer Res 8,
2912–2923.
5 Brawer MK (2005) Prostatic intraepithelial neoplasia:
an overview. Rev Urol 7 (Suppl 3), S11–S18.
6 Khani F & Robinson BD (2017) Precursor lesions of
urologic malignancies. Arch Pathol Lab Med 141, 1615–
1632.
7 De Marzo AM, Haffner MC, Lotan TL,
Yegnasubramanian S & Nelson WG (2016)
Premalignancy in prostate cancer: rethinking what we
know. Cancer Prev Res (Phila) 9, 648–656.
8 Goeman L, Joniau S, Ponette D, Van der Aa F,
Roskams T, Oyen R & Van Poppel H (2003) Is lowgrade prostatic intraepithelial neoplasia a risk factor for
cancer? Prostate Cancer Prostatic Dis 6, 305–310.
9 Franklin RA, Liao W, Sarkar A, Kim MV, Bivona
MR, Liu K, Pamer EG & Li MO (2014) The cellular
and molecular origin of tumor-associated macrophages.
Science 344, 921–925.
10 Yang L & Zhang Y (2017) Tumor-associated
macrophages: from basic research to clinical
application. J Hematol Oncol 10, 58.
11 Lin Y, Xu J & Lan H (2019) Tumor-associated
macrophages in tumor metastasis: biological roles and
clinical therapeutic applications. J Hematol Oncol 12,
76.
12 Penet MF, Kakkad S, Pathak AP, Krishnamachary B,
Mironchik Y, Raman V, Solaiyappan M & Bhujwalla
ZM (2017) Structure and function of a prostate cancer
dissemination-permissive extracellular matrix. Clin
Cancer Res 23, 2245–2254.
13 Marignol L, Coffey M, Lawler M & Hollywood D
(2008) Hypoxia in prostate cancer: a powerful shield
against tumour destruction? Cancer Treat Rev 34, 313–
327.
14 Zhou J, Schmid T, Schnitzer S & Brune B (2006)
Tumor hypoxia and cancer progression. Cancer Lett
237, 10–21.

The FEBS Journal 288 (2021) 1871–1886 ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies

1883

Macrophages accelerate cell growth of prostate cancer precursors

15 Soares CR, Shibata MA, Green JE & Jorcyk CL (2002)
Development of PIN and prostate adenocarcinoma cell
lines: a model system for multistage tumor progression.
Neoplasia 4, 112–120.
16 Dang T & Liou GY (2018) Macrophage cytokines
enhance cell proliferation of normal prostate epithelial
cells through activation of ERK and Akt. Sci Rep 8,
7718.
17 Tamamori-Adachi M, Ito H, Sumrejkanchanakij P,
Adachi S, Hiroe M, Shimizu M, Kawauchi J, Sunamori
M, Marumo F, Kitajima S et al. (2003) Critical role of
cyclin D1 nuclear import in cardiomyocyte
proliferation. Circ Res 92, e12–e19.
18 Tong W & Pollard JW (1999) Progesterone inhibits
estrogen-induced cyclin D1 and cdk4 nuclear
translocation, cyclin E- and cyclin A-cdk2 kinase
activation, and cell proliferation in uterine epithelial
cells in mice. Mol Cell Biol 19, 2251–2264.
19 Chintakuntlawar AV & Chodosh J (2009) Chemokine
CXCL1/KC and its receptor CXCR2 are responsible
for neutrophil chemotaxis in adenoviral keratitis. J
Interferon Cytokine Res 29, 657–666.
20 Deshmane SL, Kremlev S, Amini S & Sawaya BE
(2009) Monocyte chemoattractant protein-1 (MCP-1):
an overview. J Interferon Cytokine Res 29, 313–326.
21 Dewald O, Zymek P, Winkelmann K, Koerting A, Ren
G, Abou-Khamis T, Michael LH, Rollins BJ, Entman
ML & Frangogiannis NG (2005) CCL2/monocyte
chemoattractant protein-1 regulates inflammatory
responses critical to healing myocardial infarcts. Circ
Res 96, 881–889.
22 DiMartino SJ, Shah AB, Trujillo G & Kew RR (2001)
Elastase controls the binding of the vitamin D-binding
protein (Gc-globulin) to neutrophils: a potential role in
the regulation of C5a co-chemotactic activity. J
Immunol 166, 2688–2694.
23 Guo RF & Ward PA (2005) Role of C5a in
inflammatory responses. Annu Rev Immunol 23, 821–
852.
24 Sawant KV, Poluri KM, Dutta AK, Sepuru KM,
Troshkina A, Garofalo RP & Rajarathnam K (2016)
Chemokine CXCL1 mediated neutrophil recruitment:
role of glycosaminoglycan interactions. Sci Rep 6,
33123.
25 Son DS, Parl AK, Rice VM & Khabele D (2007)
Keratinocyte chemoattractant (KC)/human growthregulated oncogene (GRO) chemokines and proinflammatory chemokine networks in mouse and
human ovarian epithelial cancer cells. Cancer Biol Ther
6, 1302–1312.
26 Killian PH, Kronski E, Michalik KM, Barbieri O,
Astigiano S, Sommerhoff CP, Pfeffer U, Nerlich AG &
Bachmeier BE (2012) Curcumin inhibits prostate cancer
metastasis in vivo by targeting the inflammatory
cytokines CXCL1 and -2. Carcinogenesis 33, 2507–2519.

1884

M. U. Thomas et al.

27 Kaufmann SH, Desnoyers S, Ottaviano NE & Poirier
GG (1993) Specific proteolytic cleavage of poly(ADPribose) polymerase: an early marker for chemotherapyinduced apoptosis. Cancer Res 53, 3976–3985.
28 Mullen P (2004) PARP cleavage as a means of
assessing apoptosis. Methods Mol Med 88, 171–181.
29 Tewari M, Quan LT, O’Rourke K, Desnoyers S, Zeng
Z, Beidler DR, Poirier GG, Salvesen GS & Dixit VM
(1995) Yama/CPP32 beta, a mammalian homolog of
CED-3, is a CrmA-inhibitable protease that cleaves the
death substrate poly(ADP-ribose) polymerase. Cell 81,
801–809.
30 Liu J, Lee P, Galbiati F, Kitsis RN & Lisanti MP
(2001) Caveolin-1 expression sensitizes fibroblastic and
epithelial cells to apoptotic stimulation. Am J Physiol
Cell Physiol 280, C823–C835.
31 Wu J, Wang Y, Liang S & Ma H (2014) Cytoprotective
effect of selective small-molecule caspase inhibitors
against staurosporine-induced apoptosis. Drug Des
Devel Ther 8, 583–600.
32 Brantley DM, Chen CL, Muraoka RS, Bushdid PB,
Bradberry JL, Kittrell F, Medina D, Matrisian LM, Kerr
LD & Yull FE (2001) Nuclear factor-kappaB (NFkappaB) regulates proliferation and branching in mouse
mammary epithelium. Mol Biol Cell 12, 1445–1455.
33 Chen F, Castranova V & Shi X (2001) New insights
into the role of nuclear factor-kappaB in cell growth
regulation. Am J Pathol 159, 387–397.
34 Gururajan M, Chui R, Karuppannan AK, Ke J,
Jennings CD & Bondada S (2005) c-Jun N-terminal
kinase (JNK) is required for survival and proliferation
of B-lymphoma cells. Blood 106, 1382–1391.
35 Mebratu Y & Tesfaigzi Y (2009) How ERK1/2
activation controls cell proliferation and cell death: is
subcellular localization the answer? Cell Cycle 8, 1168–
1175.
36 Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi
Y, Ooshima A, Liu C-Y, Weng D & Kao WW-Y
(2004) Role of p38 MAP kinase in regulation of cell
migration and proliferation in healing corneal
epithelium. Invest Ophthalmol Vis Sci 45, 100–109.
37 Smith A, Ramos-Morales F, Ashworth A & Collins M
(1997) A role for JNK/SAPK in proliferation, but not
apoptosis, of IL-3-dependent cells. Curr Biol 7, 893–896.
38 Sun Y, Liu WZ, Liu T, Feng X, Yang N & Zhou HF
(2015) Signaling pathway of MAPK/ERK in cell
proliferation, differentiation, migration, senescence and
apoptosis. J Recept Signal Transduct Res 35, 600–604.
39 Yu JS & Cui W (2016) Proliferation, survival and
metabolism: the role of PI3K/AKT/mTOR signalling in
pluripotency and cell fate determination. Development
143, 3050–3060.
40 Dolcet X, Llobet D, Pallares J & Matias-Guiu X (2005)
NF-kB in development and progression of human
cancer. Virchows Arch 446, 475–482.

The FEBS Journal 288 (2021) 1871–1886 ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies

M. U. Thomas et al.

41 Pordanjani SM & Hosseinimehr SJ (2016) The role of
NF-kB inhibitors in cell response to radiation. Curr
Med Chem 23, 3951–3963.
42 Fujii T, Shimada K, Asai O, Tanaka N, Fujimoto K,
Hirao K & Konishi N (2013) Immunohistochemical
analysis of inflammatory cells in benign and
precancerous lesions and carcinoma of the prostate.
Pathobiology 80, 119–126.
43 Karakiewicz PI, Benayoun S, Begin LR, Duclos A,
Valiquette L, McCormack M, Benard F, Saad F &
Perrotte P (2007) Chronic inflammation is negatively
associated with prostate cancer and high-grade prostatic
intraepithelial neoplasia on needle biopsy. Int J Clin
Pract 61, 425–430.
44 Sfanos KS & De Marzo AM (2012) Prostate cancer
and inflammation: the evidence. Histopathology 60,
199–215.
45 Vral A, Magri V, Montanari E, Gazzano G, Gourvas
V, Marras E & Perletti G (2012) Topographic and
quantitative relationship between prostate
inflammation, proliferative inflammatory atrophy and
low-grade prostate intraepithelial neoplasia: a biopsy
study in chronic prostatitis patients. Int J Oncol 41,
1950–1958.
46 Fang LY, Izumi K, Lai KP, Liang L, Li L, Miyamoto
H, Lin W-J & Chang C (2013) Infiltrating macrophages
promote prostate tumorigenesis via modulating
androgen receptor-mediated CCL4-STAT3 signaling.
Cancer Res 73, 5633–5646.
47 Elkahwaji JE, Hauke RJ & Brawner CM (2009) Chronic
bacterial inflammation induces prostatic intraepithelial
neoplasia in mouse prostate. Br J Cancer 101, 1740–1748.
48 Kwon OJ, Zhang L, Ittmann MM & Xin L (2014)
Prostatic inflammation enhances basal-to-luminal
differentiation and accelerates initiation of prostate
cancer with a basal cell origin. Proc Natl Acad Sci USA
111, E592–E600.
49 Poutahidis T, Cappelle K, Levkovich T, Lee CW,
Doulberis M, Ge Z, Fox JG, Horwitz BH & Erdman
SE (2013) Pathogenic intestinal bacteria enhance
prostate cancer development via systemic activation of
immune cells in mice. PLoS One 8, e73933.
50 Liou GY (2017) Inflammatory cytokine signaling
during development of pancreatic and prostate cancers.
J Immunol Res 2017, 7979637.
51 Afshar-Kharghan V (2017) The role of the complement
system in cancer. J Clin Invest 127, 780–789.
52 Darling VR, Hauke RJ, Tarantolo S & Agrawal DK
(2015) Immunological effects and therapeutic role of
C5a in cancer. Expert Rev Clin Immunol 11, 255–263.
53 Markiewski MM, DeAngelis RA, Benencia F, RicklinLichtsteiner SK, Koutoulaki A, Gerard C, Coukos G &
Lambris JD (2008) Modulation of the antitumor
immune response by complement. Nat Immunol 9,
1225–1235.

Macrophages accelerate cell growth of prostate cancer precursors

54 Corrales L, Ajona D, Rafail S, Lasarte JJ, Riezu-Boj
JI, Lambris JD, Rouzaut A, Pajares MJ, Montuenga
LM & Pio R (2012) Anaphylatoxin C5a creates a
favorable microenvironment for lung cancer
progression. J Immunol 189, 4674–4683.
55 Miyake M, Lawton A, Goodison S, Urquidi V &
Rosser CJ (2014) Chemokine (C-X-C motif) ligand 1
(CXCL1) protein expression is increased in high-grade
prostate cancer. Pathol Res Pract 210, 74–78.
56 Zhang T, Tseng C, Zhang Y, Sirin O, Corn PG, LiNing-Tapia EM, Troncoso P, Davis J, Pettaway C,
Ward J et al. (2016) CXCL1 mediates obesityassociated adipose stromal cell trafficking and function
in the tumour microenvironment. Nat Commun 7,
11674.
57 Cho HJ, Kwon GT, Park H, Song H, Lee KW, Kim JI
& Park J (2015) A high-fat diet containing lard
accelerates prostate cancer progression and reduces
survival rate in mice: possible contribution of adipose
tissue-derived cytokines. Nutrients 7, 2539–2561.
58 Izhak L, Wildbaum G, Weinberg U, Shaked Y, Alami
J, Dumont D, Stein A & Karin N (2010) Predominant
expression of CCL2 at the tumor site of prostate cancer
patients directs a selective loss of immunological
tolerance to CCL2 that could be amplified in a
beneficial manner. J Immunol 184, 1092–1101.
59 Loberg RD, Day LL, Harwood J, Ying C, St John LN,
Giles R, Neeley CK & Pienta KJ (2006) CCL2 is a
potent regulator of prostate cancer cell migration and
proliferation. Neoplasia 8, 578–586.
60 Mazzucchelli L, Loetscher P, Kappeler A, Uguccioni
M, Baggiolini M, Laissue JA & Mueller C (1996)
Monocyte chemoattractant protein-1 gene expression in
prostatic hyperplasia and prostate adenocarcinoma. Am
J Pathol 149, 501–509.
61 Li X, Loberg R, Liao J, Ying C, Snyder LA, Pienta KJ
& McCauley LK (2009) A destructive cascade mediated
by CCL2 facilitates prostate cancer growth in bone.
Cancer Res 69, 1685–1692.
62 Lim SY, Yuzhalin AE, Gordon-Weeks AN & Muschel
RJ (2016) Targeting the CCL2-CCR2 signaling axis in
cancer metastasis. Oncotarget 7, 28697–28710.
63 Lin T-H, Liu H-H, Tsai T-H, Chen C-C, Hsieh T-F,
Lee S-S, Lee Y-J, Chen W-C & Tang C-H (2013) CCL2
increases alphavbeta3 integrin expression and
subsequently promotes prostate cancer migration.
Biochim Biophys Acta 1830, 4917–4927.
64 Natsagdorj A, Izumi K, Hiratsuka K, Machioka K,
Iwamoto H, Naito R, Makino T, Kadomoto S,
Shigehara K, Kadono Y et al. (2019) CCL2 induces
resistance to the antiproliferative effect of cabazitaxel in
prostate cancer cells. Cancer Sci 110, 279–288.
65 Qian DZ, Rademacher BL, Pittsenbarger J, Huang CY,
Myrthue A, Higano CS, Garzotto M, Nelson PS &
Beer TM (2010) CCL2 is induced by chemotherapy and

The FEBS Journal 288 (2021) 1871–1886 ª 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies

1885

M. U. Thomas et al.

Macrophages accelerate cell growth of prostate cancer precursors

66

67

68

69

70

71

72

protects prostate cancer cells from docetaxel-induced
cytotoxicity. Prostate 70, 433–442.
Zhang J, Patel L & Pienta KJ (2010) CC chemokine
ligand 2 (CCL2) promotes prostate cancer
tumorigenesis and metastasis. Cytokine Growth Factor
Rev 21, 41–48.
Loberg RD, Ying C, Craig M, Day LL, Sargent E,
Neeley C, Wojno K, Snyder LA, Yan L & Pienta KJ
(2007) Targeting CCL2 with systemic delivery of
neutralizing antibodies induces prostate cancer tumor
regression in vivo. Cancer Res 67, 9417–9424.
Rodriguez M, Luo W, Weng J, Zeng L, Yi Z, Siwko S
& Liu M (2014) PSGR promotes prostatic
intraepithelial neoplasia and prostate cancer xenograft
growth through NF-kappaB. Oncogenesis 3, e114.
Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A,
Preston C, Holland JF & Levine AC (2002)
Prostaglandin E(2) stimulates prostatic intraepithelial
neoplasia cell growth through activation of the
interleukin-6/GP130/STAT-3 signaling pathway.
Biochem Biophys Res Commun 290, 249–255.
Brown RE, Zotalis G, Zhang PL & Zhao B (2008)
Morphoproteomic confirmation of a constitutively
activated mTOR pathway in high grade prostatic
intraepithelial neoplasia and prostate cancer. Int J Clin
Exp Pathol 1, 333–342.
Soylu H, Acar N, Ozbey O, Unal B, Koksal IT, Bassorgun
I, Ciftcioglu A & Ustunel I (2016) Characterization of
notch signalling pathway members in normal prostate,
prostatic intraepithelial neoplasia (PIN) and prostatic
adenocarcinoma. Pathol Oncol Res 22, 87–94.
Liou GY, Doeppler H, Necela B, Edenfiled B, Zhang
L, Dawson DW & Storz P (2015) Mutant KRAS-

1886

induced expression of ICAM-1 in pancreatic acinar cells
causes attraction of macrophages to expedite the
formation of precancerous lesions. Cancer Discov 5, 52–
63.
73 Necela BM, Su W & Thompson EA (2008) Toll-like
receptor 4 mediates cross-talk between peroxisome
proliferator-activated receptor gamma and nuclear
factor-kappaB in macrophages. Immunology 125, 344–
358.

Supporting information
Additional supporting information may be found
online in the Supporting Information section at the end
of the article.
Fig. S1. Increased proliferation of PIN Pr111 cells
when co-cultured in 3D with primary macrophages.
Fig. S2. Pr111 were proliferative when co-cultured in
3D with Raw264.7 macrophage cells.
Fig. S3. Raw264.7 macrophages were proliferative in
3D co-culture with PIN Pr111 cells.
Fig. S4. Murine Pr111 cells expressed receptors
CXCR2 and CCR2.
Fig. S5. Raw264.7 macrophages increased expression
of C5a and CCL2 as cultured in co-culture media.
Fig. S6. Macrophage cytokines, C5a, CXCL1 and
CCL2 had no effect on apoptosis in murine PIN
Pr111 cells.
Fig. S7. Signaling of ERK and JNK in murine PIN
Pr111 cells stimulated by C5a, CXCL1 or CCL2.
Fig. S8. The expression of phosphorylated-Akt in the
PIN area of human prostate.
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